Sage Journals: Discover world-class research

Abstract

This study examined the concordance between multiple measures of adherence, as well as sensitivity to detection of poor adherers, specificity, and predictive validity using a daily cholesterol-lowering regimen. Participants (N = 180) aged 24 to 60 years participated in an adherence ancillary study in a clinical trial. Males constituted 53.9% of this well-educated, community sample. Data on adherence were collected over a 6-month period, using electronic monitoring, self-report, specific recall, and pill counts. Electronically monitored (odds ratio [OR] = 5.348) and Shea self-report (OR = 2.678) predicted cholesterol lowering. Days (78.9%) and intervals (84.2%) adherent and the Shea (73.7%) were sensitive to the detection of poor adherers. Moderate associations were found between measures of the same type. Low correlations were found otherwise. The electronic monitor was the most accurate and informative measure. The Shea self-report was the most accurate brief, global estimate of adherence. Other measures were not associated with clinical outcome or sensitive to poor adherence.

Keywords

adherence compliance concordance of adherence measures hyperlipidemia adherence cholesterol-lowering regimen adherence

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention. (2010).Chronic diseases and health promotion. Retrieved from http://www.cdc.gov/chronicdisease/overview/index.htm

Cook

C. L.

Wade

W. E.

Martin

B. C.

Perri

III . (2005). Concordance among three self-reported measures of medication adherence and pharmacy refill records. Journal of the American Pharmacists Association, 45, 151-159.

Cramer

Vachon

Desforges

Sussman

N. M.

(1995). Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia, 36, 1111-1117.

Egan

B. M.

Zhao

Axon

R. N.

(2010). US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. Journal of the American Medical Association, 303, 2043-2050.

Einstein

G. O.

McDaniel

M. A.

Smith

Shaw

(1998). Habitual prospective memory and aging: Remembering instructions and forgetting actions. Psychological Science, 9, 284-288.

Fan

Koro

C. E.

Bowlin

S. J.

Fedder

D.O.

(2005, June). Treatment patterns and glycemic control changes between NHANES III (1988-1994) and NHANES 1999-2002 among US adults diagnosed with type 2 diabetes. Paper presented at the American Diabetes Association Scientific Convention. San Diego, CA. Abstract Retrieved from http://professional.diabetes.org/Abstracts_Display.aspx?TYP=1&CID=50693

Ford

E. S.

Pearson

W. S.

Zhao

Mokdad

A. H.

(2010). Trends in hypercholesterolemia, treatment, and control among United States adults. International Journal of Cardiology, 140, 226-235.

Garber

M. C.

Nau

D. P.

Erickson

S. R.

Aikens

J. E.

Lawrence

J. B.

(2004). The concordance of self-report with other measures of medication adherence: A summary of the literature. Medical Care, 42, 649-652.

Hansen

R. A.

Kim

M. M.

Song

Murray

M. D.

(2009). Comparison of methods to assess medication adherence and classify nonadherence. Annals of Pharmacotherapy, 43, 413-422.

10.

Haynes

R. B.

Ackloo

Sahota

McDonald

H. P.

Yao

(2008). Interventions for enhancing adherence to prescribed medications. Cochran Database of Systematic Reviews, 16, CD000011.

11.

Haynes

R. B.

Sackett

D. L.

Gibson

E. S.

Taylor

D. W.

Hackett

B. C.

Roberts

R. S.

Johnson

A. L.

(1976). Improvement of medication compliance in uncontrolled hypertension. Lancet, 1, 1265-1268.

12.

Haynes

R. B.

Taylor

Sackett

D. L.

Gibson

E. S.

Bernholz

C. D.

Mukherjee

(1980). Can simple clinical measurements detect patient noncompliance? Hypertension, 2, 757-764.

13.

Johnson

Raye

C. L.

(1981). Reality monitoring. Psychological Review, 88, 67-85.

14.

Kruse

Rampmaier

Ullrich

&Weber

(1994). Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. International Journal of Clinical Pharmacology and Therapeutics, 32, 452-457.

15.

Linton

M. E.

(1982). Transformations of memory in everyday life. In Neisser

(Ed.), Memory observed: Remembering natural contexts (pp. 77-91). San Francisco, CA: W. H. Freeman.

16.

Liu

Golin

C. E.

Miller

L. G.

Hays

R. D.

Beck

C. K.

Sanandaji

Wenger

N. S.

(2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.

17.

Means

B. N. S.

Loftus

E. F.

(1991). When personal history repeats itself: Decomposing memories for recurring events. Applied Cognitive Psychology, 5, 297-318.

18.

Morisky

D. E.

Green

L. W.

Levine

D. M.

(1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24, 67-74.

19.

Muldoon

M. F.

Barger

S. D.

Ryan

C. M.

Flory

J. D.

Lehoczky

J. P.

Matthews

K. A.

Manuck

S. B.

(2000). Effects of lovastatin on cognitive function and psychological well-being. American Journal of Medicine, 108, 538-546.

20.

Pearson

C. R.

Simoni

J. M.

Hoff

Kurth

A. E.

Martin

D. P.

(2007). Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues. AIDS Behavior, 11, 161-173.

21.

Rand

C. S.

(2000). I took the medicine like you told me doctor: Self-report of adherence to medical regimens. In Stone

A. A.

Turkkan

J. S.

Bachrach

C. A.

Jobe

J. B.

Kurtzman

H. S.

Cain

V. S.

(Eds.), The science of self-report: Implications for research and practice (pp. 257-276). Mahwah, NJ: Erlbaum.

22.

Raphael

(1987). Recall bias: A proposal for assessment and control. International Journal of Epidemiology, 16, 167-170.

23.

Riekert

K. A.

Rand

C. S.

(2002). Electronic monitoring of medication adherence: When is high-tech best? Journal of Clinical Psychology in Medical Settings, 9, 25-34.

24.

Sabate

(Ed.). (2003). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization. Retrieved from http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf

25.

Shea

Misra

Ehrlich

M. H.

Field

Francis

C. K.

(1992). Correlates of nonadherence to hypertension treatment in an inner-city minority population. American Journal of Public Health, 82, 1607-1612.

26.

The Milliken Institute. (2011). An unhealthy America: The economic burden of chronic disease. Retrieved from http://www.chronicdiseaseimpact.com/ebcd.taf

27.

Velligan

D. I.

Wang

Diamond

Glahn

D. C.

Castillo

Bendle

. . . Miller

A. I.

(2007). Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services, 58, 1187-1192.

28.

Wagner

Miller

L. G.

(2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndrome, 35, 203-204.

29.

Walsh

J. C.

Mandalia

Gazzard

B. G.

(2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. Acquired Immunodeficiency Syndrome, 16, 269-277.

30.

Wang

Brockmeier

(2002). Autobiographical remembering as cultural practice: Understanding the interplay between memory, self and culture. Culture & Psychology, 8, 45-64.

Accuracy of Measures of Medication Adherence in a Cholesterol-Lowering Regimen

Abstract

Keywords

Get full access to this article

References